tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Schwartz, 5 are a BUY (71.43%), 2 are a HOLD (28.57%).
Analyst Steven Schwartz, carries an average stock price target met ratio of 100% that have a potential upside of 54.46% achieved within 130 days. Previously, Steven Schwartz worked at FIRST ANALYSIS.
Steven Schwartz’s has documented 14 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RGEN, Repligen at 27-Aug-2019.
Analyst best performing recommendations are on CDMO (AVID BIOSERVICES).
The best stock recommendation documented was for CDMO (AVID BIOSERVICES) at 3/13/2018. The price target of $4 was fulfilled within 111 days with a profit of $2.25 (128.57%) receiving and performance score of 11.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Mar-2021
$12
$-0.49 (-3.92%)
$12
1 years 11 months 23 days ago
(07-Nov-2024)
10/14 (71.43%)
$-0.24 (-1.96%)
27
Buy Since 10-Nov-2020
$14
$1.51 (12.09%)
$14
2 years 1 months ago
(30-Sep-2024)
2/5 (40%)
$2.62 (23.02%)
86
Buy Since 17-Oct-2019
$12
$-0.49 (-3.92%)
$12
2 years 1 months 20 days ago
(10-Sep-2024)
3/7 (42.86%)
$1.51 (14.39%)
90
Buy Since 16-Oct-2019
$16
$3.51 (28.10%)
$22
2 years 10 months 22 days ago
(08-Dec-2023)
2/6 (33.33%)
$11.36 (244.83%)
266
Buy
$20
$11.76 (142.72%)
$22
3 years 4 months 8 days ago
(22-Jun-2023)
1/4 (25%)
$6.26 (45.56%)
92
